Styrenic block copolymers for biomaterial and drug delivery applications

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Medical Device Engineering

Background:

• Styrenic block copolymers show renewed promise as biomaterials and drug delivery matrices.
• Past limitations in implantable medical devices were due to a lack of understanding of microphase separation's biological impact.
• Recent advances illuminate how microphase separation influences biological responses.

Purpose of the Study:

• To highlight the renaissance of styrenic block copolymers as advanced biomaterials.
• To underscore the critical properties of poly(styrene-b-isobutylene-b-styrene) (SIBS) for medical applications.
• To discuss the role of SIBS in current and future medical device development.

Main Methods:

• Review of scientific literature on styrenic block copolymers and their applications.
• Analysis of the physical and biological properties of SIBS.
• Case study of SIBS utilization in the TAXUS coronary stent for paclitaxel delivery.

Main Results:

• Poly(styrene-b-isobutylene-b-styrene) (SIBS) exhibits crucial properties for processing, vascular compatibility, and bio-stability.
• SIBS serves as the matrix for paclitaxel delivery in Boston Scientific's TAXUS coronary stent.
• Understanding microphase separation is key to mediating biological responses.

Conclusions:

• SIBS possesses enabling properties that have revitalized its use in medical devices.
• The unique characteristics of SIBS support the development of advanced medical devices meeting stringent requirements.
• Continued innovation in SIBS-based medical devices is anticipated.